Suzanne Bruhn is a distinguished biopharmaceutical leader and the CEO of the Charcot-Marie-Tooth Association. Her career is dedicated to developing therapies for rare diseases and neuroscience. She holds a PhD from MIT and was a postdoctoral fellow at Harvard Medical School, leveraging deep scientific expertise across numerous executive and board director roles.
Fueled by a passion for patient-focused drug development, she is deeply committed to patient advocacy and community support. A press release from November 2023 notes she lives in New Hampshire with her husband and has two adult sons.
She has successfully negotiated deals valued at over a billion dollars, such as an agreement with Bristol Myers Squibb for the right to acquire Promedior.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.